Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
International Journal of Molecular Sciences
|
February 24, 2024
Emerging Gene Therapeutics for Epidermolysis Bullosa under Development
Johannes Bischof, Markus Hierl, Ulrich Koller
ACS Omega
|
January 23, 2023
Tritium Labeling of Neuromedin S by Conjugation with [<sup>3</sup>H]<i>N</i>-Succinimidyl Propionate
Martin R Edelmann, Johannes Erny, Wolfgang Guba, et al.
Free Radical Biology & Medicine
|
May 22, 2003
Cloning of novel human SEC14p-like proteins: ligand binding and functional properties
Petra Kempná, Jean-Marc Zingg, Roberta Ricciarelli, et al.
Journal of Medicinal Chemistry
|
July 14, 2025
Machine Learning-Assisted Iterative Screening for Efficient Detection of Drug Discovery Starting Points
Alex T Müller, Markus Hierl, Dominik Heer, et al.
Journal of Biomolecular Screening
|
August 24, 2011
High-throughput TR-FRET assays for identifying inhibitors of LSD1 and JMJD2C histone lysine demethylases
Violeta Yu, Tanja Fisch, Alexander M Long, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 23, 2008
Synthesis and activity of substituted carbamates as potentiators of the alpha4beta2 nicotinic acetylcholine receptor
Stephanie K Springer, Katrina S Woodin, Virginia Berry, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 16, 2008
Discovery and optimization of substituted piperidines as potent, selective, CNS-penetrant alpha4beta2 nicotinic acetylcholine receptor potentiators
Brian K Albrecht, Virginia Berry, Alessandro A Boezio, et al.
Cell Chemical Biology
|
December 2, 2023
Selective and brain-penetrant HCN1 inhibitors reveal links between synaptic integration, cortical function, and working memory
Eva Harde, Markus Hierl, Michael Weber, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 1, 2025
Prime editing as a promising therapeutic strategy for junctional epidermolysis bullosa
Markus Hierl, Johannes Bischof, Bernadette Liemberger, et al.
Pain
|
February 20, 2010
Pharmacological effects of nonselective and subtype-selective nicotinic acetylcholine receptor agonists in animal models of persistent pain
BaoXi Gao, Markus Hierl, Kristie Clarkin, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
International Journal of Molecular Sciences
|
February 24, 2024
Emerging Gene Therapeutics for Epidermolysis Bullosa under Development
Johannes Bischof, Markus Hierl, Ulrich Koller
ACS Omega
|
January 23, 2023
Tritium Labeling of Neuromedin S by Conjugation with [<sup>3</sup>H]<i>N</i>-Succinimidyl Propionate
Martin R Edelmann, Johannes Erny, Wolfgang Guba, et al.
Free Radical Biology & Medicine
|
May 22, 2003
Cloning of novel human SEC14p-like proteins: ligand binding and functional properties
Petra Kempná, Jean-Marc Zingg, Roberta Ricciarelli, et al.
Journal of Medicinal Chemistry
|
July 14, 2025
Machine Learning-Assisted Iterative Screening for Efficient Detection of Drug Discovery Starting Points
Alex T Müller, Markus Hierl, Dominik Heer, et al.
Journal of Biomolecular Screening
|
August 24, 2011
High-throughput TR-FRET assays for identifying inhibitors of LSD1 and JMJD2C histone lysine demethylases
Violeta Yu, Tanja Fisch, Alexander M Long, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 23, 2008
Synthesis and activity of substituted carbamates as potentiators of the alpha4beta2 nicotinic acetylcholine receptor
Stephanie K Springer, Katrina S Woodin, Virginia Berry, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 16, 2008
Discovery and optimization of substituted piperidines as potent, selective, CNS-penetrant alpha4beta2 nicotinic acetylcholine receptor potentiators
Brian K Albrecht, Virginia Berry, Alessandro A Boezio, et al.
Cell Chemical Biology
|
December 2, 2023
Selective and brain-penetrant HCN1 inhibitors reveal links between synaptic integration, cortical function, and working memory
Eva Harde, Markus Hierl, Michael Weber, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 1, 2025
Prime editing as a promising therapeutic strategy for junctional epidermolysis bullosa
Markus Hierl, Johannes Bischof, Bernadette Liemberger, et al.
Pain
|
February 20, 2010
Pharmacological effects of nonselective and subtype-selective nicotinic acetylcholine receptor agonists in animal models of persistent pain
BaoXi Gao, Markus Hierl, Kristie Clarkin, et al.
Page
of 2